Insulin-Like Growth Factor 2 in Development and Disease: A Mini-Review
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
Background: Insulin-like growth factor 2 (IGF2) is a protein hormone known to regulate cell proliferation, growth, migration, differentiation and survival. The gene is parentally imprinted in the sense that transcripts are almost exclusively derived from the paternal allele. Loss of imprinting of the IGF2 gene is a recurrent observation in growth disorders that combine overgrowth with a variety of malignant tumours. Moreover, IGF2 has been proposed to play a role in the development of a variety of seemingly unrelated cancers that play an important role in geriatric medicine, e.g. breast cancer, colon cancer and lung cancer. Finally, IGF2 has been implicated in cardiovascular disease, since, for example, IGF2 has been shown to influence the size of atherosclerotic lesions. Objective: To summarize current knowledge about IGF2, its interactions with binding proteins and receptors and connections with key diseases. Methods: The contents of this paper were based on reviews of existing literature within the field. Results: There is a substantial amount of research linking IGF2 to growth disorders, cancer and to a much lesser degree cardiovascular disease. Some of the studies on IGF2 and tumour growth have yielded conflicting results, for instance regarding its effect on apoptosis. Conclusion: Today, our knowledge on how IGF2 is composed and interacts with receptors has come a long way. However, there is comparatively little information on how IGF2 affects tumour growth and cardiovascular diseases such as atherosclerosis. Thus, further research will be needed to elucidate the impact of IGF2 on key diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genes whose expression significantly decreased include Mki67 and Igf2, which have roles in promoting cellular proliferation40,41.”
From The single-cell transcriptional landscape of mammalian organogenesis (2019) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Parental imprinting of the mouse insulin-like growth factor II gene
DeChiara, T. M., Robertson, E. J., & Efstratiadis, A. (1991) · Cell · doi:10.1016/0092-8674(91)90513-x · Cited by 1,783
Rinderknecht, E., & Humbel, R. E. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)40889-1 · Cited by 1,545
Insulin-like growth factors and neoplasia
Pollak, M. N., Schernhammer, E. S., & Hankinson, S. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1387 · Cited by 1,463
A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro.
SALMON, W. D., & Daughaday, W. H. (1957) · PubMed · Cited by 1,084
Belfiore, A., Frasca, F., Pandini, G., Sciacca, L., & Vigneri, R. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0047 · Cited by 1,033
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 1,005
Primary structure of human insulin‐like growth factor II
Rinderknecht, E., & Humbel, R. E. (1978) · FEBS Letters · doi:10.1016/0014-5793(78)80237-3 · Cited by 780
Insulin-like growth factor binding proteins and their role in controlling IGF actions
Clemmons, D. R. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00053-6 · Cited by 498
Structure and autoregulation of the insulin-like growth factor 1 receptor kinase.
Favelyukis, S., Till, J. H., Hubbard, S. R., & Miller, W. T. (2001) · Nature Structural Biology · doi:10.1038/nsb721 · Cited by 336
IGF2: Epigenetic regulation and role in development and disease
Chao, W., & D’Amore, P. A. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.01.005 · Cited by 336
Cited by
Items 101–200 of 260
Valleh, M. V., Hyttel, P., Rasmussen, M. A., & Strøbech, L. (2014) · Theriogenology · doi:10.1016/j.theriogenology.2014.07.003 · Cited by 14
“Recent evidence suggests that activation of phosphatidylinositol 3kinase-AKT/protein kinase B, which is activated on binding of IGF-II to its receptor [68], could in turn lead to activation of transcription of the BCL2-L1 gene [67].”
BackgroundRauner, G., Kudinov, T., Gilad, S., Hornung, G., & Barash, I. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.05.013 · Cited by 14
Highlights on selected growth factors and their receptors as promising anticancer drug targets
Mansour, M. A., Caputo, V. S., & Aleem, E. A. (2021) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2021.106087 · Cited by 15
Ox-LDL Upregulates CRP Expression Through the IGF2 Pathway in THP-1 Macrophages
Li, S., Hu, Y., Zhao, J., Ma, X., Wu, S.-G., Lu, J., Hu, Y.-R., Wang, Y., Gao, J.-J., Sha, Y.-H., et al. (2014) · Inflammation · doi:10.1007/s10753-014-9964-4 · Cited by 15
Imprinting genes associated with endometriosis
Kobayashi, H. (2014) · EXCLI journal · doi:10.17877/de290r-176 · Cited by 18
“…important spheres including developmental (Jacobi et al., 2013; Wetendorf and DeMayo, 2012; Kajimura et al., 2010; Matsumoto et al., 2006; Yuen et al., 2011; Bergman et al., 2013; Lambertini et al., 2012; Godfrey et al., 2011), transport (Balsa et al., 2012; Burger et al., 2010), regulatory…”
InfluentialJung, S. Y., Ho, G. Y. F., Rohan, T. E., Strickler, H. D., Bea, J. W., Papp, J. C., Sobel, E. M., Zhang, Z., & Crandall, C. J. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4272-y · Cited by 14
“The PI3K/Akt pathway leads to metabolic activity, including glucose uptake and decreased apoptosis, and the MAPK pathway leads to mitogenic activity [54]; both are main signaling cascades in controlling cellular process promoting carcinogenesis [55, 56].”
BackgroundNot just neurons: The diverse cellular landscape of learning and memory
Alberini, C. M. (2025) · Neuron · doi:10.1016/j.neuron.2025.05.005 · Cited by 17
Lin, P., Xu, M. J., Yang, Q., Chen, M., & Guo, S. (2023) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2023.108708 · Cited by 13
Insulin-like growth factor-2 regulates basal retinal insulin receptor activity
Zolov, S. N., Imai, H., Losiewicz, M. K., Singh, R. S., Fort, P. E., & Gardner, T. W. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100712 · Cited by 13
“Previous studies have shown that IGF-1 and IGF-2 are important for cell growth (20), so transcript levels were compared by qPCR in P7 pups and adult rats.”
BackgroundlncINS-IGF2 Promotes Cell Proliferation and Migration by Promoting G1/S Transition in Lung Cancer
Gao, S., Lin, Z., Li, C., Wang, Y., Yang, L., Zou, B., Chen, J., Li, J., Feng, D., Song, Z., et al. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818823029 · Cited by 13
The science behind the relations among cancer, height, growth patterns, and growth hormone axis
Boguszewski, C. L., Boguszewski, M. C. D. S., & de Herder, W. W. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0400 · Cited by 12
Rogers, M. A., Kalter, V., Strowitzki, M. J., Schneider, M. A., & Lichter, P. (2016) · Tumor Biology · doi:10.1007/s13277-016-5115-x · Cited by 12
“Addition of IGF2 to SW480 cells was shown previously to increase proliferation [32], and both pro and antiapoptotic effects of IGF2 in other tissues have been previously described [2, 11].”
BackgroundSaeui, C. T., Cho, K. C., Dharmarha, V., Nairn, A. V., Galizzi, M., Shah, S. R., Gowda, P. C., Park, M., Austin, M. A., Clarke, A., et al. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.00013 · Cited by 13
“Finally, introduction of exogenously-supplied ManNAc (or ManNAc Abbreviations: FAT1, FAT atypical cadherin 1; FKBP10, FKBP prolyl isomerase 10; GNE, UDP-GlcNAc 2-epimerase/ManNAc kinase; GO, gene ontology; HYOU1, hypoxia up-regulated protein 1; IGF2R, insulin-like growth factor 2 receptor; L1CAM, L1 cell adhesion mole…”
BackgroundInfluentialVadlakonda, L., Indracanti, M., Kalangi, S. K., Gayatri, B. M., Gajula, N. N., & Reddy, A. B. M. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00566-5 · Cited by 11
Bánki, T., Drost, J., van den Heuvel‐Eibrink, M. M., Mavinkurve‐Groothuis, A. M. C., & de Krijger, R. R. (2023) · Cancers · doi:10.3390/cancers15051363 · Cited by 11
“H19 and IGF-2 are two parentally imprinted genes on 11p15, with opposite regulatory mechanisms: if H19 is silenced, IGF-2 on the other hand is upregulated [50,51].”
BackgroundSynergic Action of Insulin-like Growth Factor-2 and miRNA-483 in Pterygium Pathogenesis
Maxia, C., Isola, M., Grecu, E., Cuccu, A., Scano, A., Orrù, G., Girolamo, N. D., Diana, A., & Murtas, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054329 · Cited by 12
“Furthermore, IGF-2 is a natural ligand for IR-A with affinity properties related to the receptor close to the same insulin, and for IGF-1R, competing with IGF-1 [19,23,24].”
BackgroundCorrelation of IGFBP-6 expression with apoptosis and migration of colorectal carcinoma cells
Qiu, F., Gao, W., & Wang, B. (2018) · Cancer Biomarkers · doi:10.3233/cbm-170947 · Cited by 11
“In IGFs super-family, IGFBP-6 had the closet correlation with biology effect of IGF-2 [3].”
Brütting, C., Narasimhan, H., Hoffmann, F. A., Kornhuber, M. E., Staege, M. S., & Emmer, A. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00287 · Cited by 12
“Moreover, it plays a role in the growth and development of tumors: epigenetic changes at this locus are for example associated with Wilms tumor, Beckwith–Wiedemann syndrome, or rhabdomyosarcoma (Bergman et al., 2013).”
BackgroundPleomorphic adenoma gene1 in reproduction and implication for embryonic survival in cattle: a review
D’Occhio, M. J., Campanile, G., Baruselli, P. S., Porto-Neto, L. R., Hayes, B. J., Snr, A. C., & Fortes, M. R. S. (2024) · Journal of Animal Science · doi:10.1093/jas/skae103 · Cited by 11
“IGF2 codes for the IGF2 protein which is an important fetal mitogen (O’Dell & Day, 1998; Curchoe et al., 2005; Berkowicz et al., 2010; Bergman et al., 2013).”
BackgroundSandovici, I., Fernandez‐Twinn, D. S., Campbell, N., Cooper, W. N., Sekita, Y., Zvetkova, I., Ferland-McCollough, D., Prosser, H. M., Oyama, L. M., Pantaleão, L. C., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114750 · Cited by 12
Genes Downregulated in Endometriosis Are Located Near the Known Imprinting Genes
Kobayashi, H., Higashiura, Y., Koike, N., Akasaka, J., Uekuri, C., Iwai, K., Niiro, E., Morioka, S., & Yamada, Y. (2014) · Reproductive Sciences · doi:10.1177/1933719114526473 · Cited by 10
Insulin-like Growth Factors may be Markers of both Traumatic Brain Injury and Fear-Related Stress
Corne, R., Besson, V. C., Slimane, S. A. S., Coutan, M., Palhas, M. L. C., Shen, F. X., Marchand‐Leroux, C., Ogier, M., & Mongeau, R. (2021) · Neuroscience · doi:10.1016/j.neuroscience.2021.04.013 · Cited by 10
Kingshott, G., Biernacka, K. M., Sewell, A., Gwiti, P., Barker, R. M., Zielinska, H., Gilkes, A., McCarthy, K. L., Martin, R. M., Lane, J. A., et al. (2021) · Cancers · doi:10.3390/cancers13040825 · Cited by 9
“Of the three IMPs (IMP1, IMP2 and IMP3) identified [45], IMP3 has been shown to activate translation of mRNA by binding to the coding regions of IGF-II [46].”
Neuropeptides as the Shared Genetic Crosstalks Linking Periodontitis and Major Depression Disorder
Sun, C., Han, J., Bai, Y., Zhong, Z., Song, Y., & Sun, Y. (2021) · Disease Markers · doi:10.1155/2021/3683189 · Cited by 11
Yitayew, M. Y., Luginina, M., & Tabrizian, M. (2024) · Advanced NanoBiomed Research · doi:10.1002/anbr.202300097 · Cited by 9
The IGF pathway is activated in insulinomas but downregulated in metastatic disease
Henfling, M. E. R., Perren, A. A., Schmitt, A. M., Saddig, C., Starke, A. A. R., Riedl, R. G., Versleijen‐Jonkers, Y. M. H., Sprij-Mooij, D. M., Ramaekers, F. C. S., Hofland, L. J., et al. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0222 · Cited by 9
Jung, S. Y., & Zhang, Z. (2019) · Menopause The Journal of The North American Menopause Society · doi:10.1097/gme.0000000000001301 · Cited by 10
Demetz, G., Oostendorp, R. A. J., Boxberg, A. M., Sitz, W., Farrell, E. V., Steppich, B., Steinsiek, A.-L., Rudelius, M., & Ott, I. (2017) · Journal of Vascular Research · doi:10.1159/000479872 · Cited by 9
The Molecular Biology of Placental Transport of Calcium to the Human Foetus
Walker, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26010383 · Cited by 8
Abruzzese, G. A., Arboccó, F. C. V., Ferrer, M. J., Silva, A. F., & Motta, A. B. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32554-0_2 · Cited by 8
H19ICR mediated transcriptional silencing does not require target promoter methylation
Gebert, C. M., Rong, Q., Jeong, S., Iben, J., & Pfeifer, K. E. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.042 · Cited by 8
Ordyan, N. E., Malysheva, O. V., Акулова, В. К., Пивина, С. Г., & Kholova, G. I. (2020) · Neurochemical Journal · doi:10.1134/s1819712420020075 · Cited by 8
Activation of Proneuronal Transcription Factor Ascl1 in Maternal Liver Ensures a Healthy Pregnancy
Lee, J., Garcia, V., Nambiar, S. M., Jiang, H., & Dai, G. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.08.009 · Cited by 9
Fowler, E. W., van Venrooy, E. J., Witt, R. L., & Jia, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-19253-x · Cited by 11
Niculescu, V. F. (2024) · Academia Medicine · doi:10.20935/acadmed6168 · Cited by 13
Takama, Y., Kubota, A., Nakayama, M., Higashimoto, K., Jozaki, K., & Soejima, H. (2014) · Pediatrics International · doi:10.1111/ped.12406 · Cited by 8
Impact of Scaling and Periodontal Treatment during Pregnancy on the Risk of Adverse Birth Outcomes
Chen, J.-J., Wu, D.-R., Lin, W., Chen, I., Liu, J.-F., Chen, H., & Lin, C. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020137 · Cited by 10
“a peptide hormone that plays a key role in regulating cell proliferation, growth, migration, differentiation and apoptosis [31], showing that IGF-2 is a critical regulating factor in fetal growth and embryo development.”
BackgroundTargeting IRES-dependent translation as a novel approach for treating Duchenne muscular dystrophy
Péladeau, C. L., & Jasmin, B. J. (2020) · RNA Biology · doi:10.1080/15476286.2020.1847894 · Cited by 7
“IGF-2 can interact with the IGF-1 receptor (IGF1 R) to activate phosphatidylinositol 3-kinase/Akt signalling, which in turn blocks proteolytic processing of key caspases and prevents initiation of the apoptotic cascade [231,234].”
BackgroundKaneko, N., Ishikawa, T., & Nomura, K. (2023) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2023.110826 · Cited by 6
Klimentová, J., Řehulka, P., Stulík, J., Vozandychova, V., Řehulková, H., Jurčová, I., Lazárová, M., Aiglová, R., Dokoupil, J., Hrečko, J., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.3c00691 · Cited by 6
“39 Moreover, the mice overexpressing IGF2 evolved abnormalities in cardiac architecture, namely enlarged left ventricle.”
BackgroundCancer and insulin-like growth factor inhibitors: Recent advancements and SAR analysis
Choudhary, D., Kumar, B., & Thakur, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-96121-9.00008-5 · Cited by 6
Shrilakshmi, S., Kundapura, S. V., Dey, D., Palaniappan, C., Sekar, K., Ananda, K., & Ramagopal, U. A. (2024) · Molecular Informatics · doi:10.1002/minf.202300160 · Cited by 6
Jung, S. Y., Papp, J. C., Sobel, E. M., & Zhang, Z. (2017) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-17-0143 · Cited by 7
Genetic Variation in the H19 - IGF2 Cluster Might Confer Risk of Developing Impaired Renal Function
Coto, E., Corte, C. D., Tranche, S., Gómez, J., Reguero, J. R., Alonso, B., Iglesias, S., Gil‐Peña, H., Yin, X., & Coto‐Segura, P. (2018) · DNA and Cell Biology · doi:10.1089/dna.2017.4135 · Cited by 6
“Conversely, when these sites are unmethylated, the H19 lncRNA is expressed but the IGF2 transcription is blocked (Chao et al., 2008; Bergman et al., 2013).”
Foroutan, A., Devos, J., Wishart, D. S., Li, C., Colazo, M. G., Kastelic, J. P., Thundathil, J. C., & Fitzsimmons, C. (2020) · Livestock Science · doi:10.1016/j.livsci.2020.104365 · Cited by 13
In vitro transcriptome response to propolis in differentiated SH‐SY5Y neurons
Türkez, H., Arslan, M. E., Yilmaz, A., Doru, F., Çağlar, Ö., Arslan, E., Tatar, A., Hacımüftüoğlu, A., El‐Aty, A. M. A., & Mardinoğlu, A. (2021) · Journal of Food Biochemistry · doi:10.1111/jfbc.13990 · Cited by 8
A brief glimpse of a tangled web in a small world: Tumor microenvironment
Talaat, I. M., & Kim, B. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1002715 · Cited by 6
Intergenerational transmission of stress-related epigenetic regulation
Collins, N. J., & Roth, T. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819262-7.00007-6 · Cited by 9
RETRACTED: Identification of IGF2 promotes skin wound healing by co‐expression analysis
Liu, X., Teng, Y., Li, H., Luo, D., Li, H., Shen, J., Du, S., Zhang, Y., Wang, D., & Jing, J. (2024) · International Wound Journal · doi:10.1111/iwj.14862 · Cited by 5
“25,26 IGF2 mainly promotes cell proliferation, growth, and survival by binding to tyrosine kinase receptors (RTKs) and activating downstream signalling pathways such as MAPK, PI3K/AKT.”
BackgroundRetractedExploratory DNA methylation analysis in post-mortem heart tissue of sudden unexplained death
Sutter, C., Haas, C., Bode, P. K., Neubauer, J., & Andersen, J. D. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01777-w · Cited by 5
Sakarin, S., Rungsipipat, A., Roytrakul, S., Jaresitthikunchai, J., Phaonakrop, N., Charoenlappanit, S., Thaisakun, S., & Surachetpong, S. D. (2024) · PLoS ONE · doi:10.1371/journal.pone.0296068 · Cited by 5
Yundung, Y., Mohammed, S., Paneni, F., Reutersberg, B., Rössler, F., Zimmermann, A., & Pelisek, J. (2024) · Scientific Reports · doi:10.1038/s41598-024-59164-7 · Cited by 5
“IGF2BPs bind specific sets of RNAs, regulating their translation, stability, and subcellular localisation 67 .”
BackgroundInsulin-Like Growth Factor 2 in Physiology, Cancer, and Cancer Treatment
Röttgering, B., & Szuhai, K. (2019) · OBM Genetics · doi:10.21926/obm.genet.1904096 · Cited by 5
Suzukawa, A. A., Zanluca, C., Jorge, N. A. N., de Noronha, L., Koishi, A. C., de Paula, C. B. V., Rebutini, P. Z., Nagashima, S., Hansel-Frose, A., Parreira, V. D. S. C., et al. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.09.028 · Cited by 6
Genetic ablation of the preptin-coding portion of Igf2 impairs pancreatic function in female mice
Buckels, E. J., Hsu, H.-L., Buchanan, C. M., Matthews, B. G., & Lee, K. L. (2022) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00401.2021 · Cited by 5
Case report: A novel de novo IGF2 missense variant in a Finnish patient with Silver-Russell syndrome
Loid, P., Lipsanen‐Nyman, M., Ala‐Mello, S., Hannula‐Jouppi, K., Kere, J., Mäkitie, O., & Muurinen, M. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.969881 · Cited by 5
Lémamy, G. J., Ndeboko, B., Omouessi, S. T., & Mouécoucou, J. (2016) · InTech eBooks · doi:10.5772/64810 · Cited by 5
“Genomic imprinting is a developmental gene regulation whereby only one of the parental alleles is expressed [9].”
BackgroundInfluentialDynamics of Neurogenic Signals as Biological Switchers of Brain Plasticity
Moreira, J. A. F., & Solá, S. (2024) · Stem Cell Reviews and Reports · doi:10.1007/s12015-024-10788-2 · Cited by 6
“The binding of IGF-II to IGF-1R, which is expressed widely in the brain [ 57 ], triggers downstream activation of cell proliferation-related MAPK and phosphoinositide 3-kinase (PI3K) -Akt—forkhead box (FOXO) pathways [ 58, 59].”
BackgroundZhao, Y., Liao, Y., Li, P., de Gonzalez, R. S., Chen, X., Nieto, N. S., Brunel, F. M., Cox, N., Stock, J. R., McHenry, M., et al. (2026) · Advanced Science · doi:10.1002/advs.202518793 · Cited by 5
“Consequently, LYTAC degraders incorporating these ligands may carry a risk of mitogenic side effects such as stimulation of cancer cell growth, cardiovascular issues, and growth abnormalities [ 29 ].”
Rodrigues, G. R. D., Cyrillo, J. N. D. S. G., Mota, L. F. M., Schmidt, P. I., Valente, J. P. S., Oliveira, E. S., de Albuquerque, L. G., Brito, L. F., & Mercadante, M. E. Z. (2025) · Scientific Reports · doi:10.1038/s41598-025-88501-7 · Cited by 4
Özmen, Ö. (2020) · Acta Veterinaria Hungarica · doi:10.1556/004.2020.00044 · Cited by 4
“The results of this study show that IGFI and IGF-II may be used to evaluate benign and malignant tumours, and due to the close relationship between increased expression and malignancy, their inhibition may be used for treatment approaches in the future.”
BackgroundInfluentialShimizu, M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820649-2.00075-9 · Cited by 5
Insulin-Like Growth Factor 2: New Roles for a Known Molecule
Malysheva, O. V., & Ordyan, N. E. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01218-2 · Cited by 4
Li, J., Jiang, X., Wang, Q., Wu, X., Qu, Z., Song, T., Wan, W., Zheng, X., & Yi, X. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.960105 · Cited by 4
“IGF2 is crucial in regulating cell proliferation, growth, migration, differentiation, and survival by interacting with several receptors and binding proteins (36).”
BackgroundJian, X., & Felsenfeld, G. (2021) · Nature Communications · doi:10.1038/s41467-021-24635-2 · Cited by 5
IGF2 revs the steroidogenesis engine
Comstock, C. E. S., & Knudsen, K. E. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0243 · Cited by 5
“Notably, high levels of IGF2 have been implicated with increased risk for development of a variety of solid malignancies, including cancers of the breast, lung, bladder, endometrium, and prostate (Bergman et al. 2012).”
Epigenetic Mosaicism in Genomic Imprinting Disorders
Sazhenova, E. A., & Лебедев, И. Н. (2019) · Russian Journal of Genetics · doi:10.1134/s1022795419100119 · Cited by 6
Evaluation of circulating IGF-I and IGFBP-3 as biomarkers for tumors in dogs
Song, D.-W., Ro, W., Sur, J., Seung, B., Kang, H.-M., Kim, J.-W., Park, S., & Park, H. (2021) · Journal of Veterinary Science · doi:10.4142/jvs.2021.22.e77 · Cited by 3
“IGF-II is expressed during the fetal period to facilitate development, whereas IGF-I plays a role in adults [2].”
BackgroundLiao, L., Zhou, X., Zhang, M., Lin, T., Long, W., Yan, Y., Ning, Q., & Luo, X. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003324 · Cited by 5
“[9,30,31] Moreover, a study indicated that the PI3K/AKT2 molecular pathway was mainly involved in cell survival, cell growth, and glycolipid metabolism regulation.”
The Paradigms in Breast Cancer Prevention
Janssens, J. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-27135-4_1 · Cited by 3
Epigenetic processes—An overview
Raleigh, S. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820682-9.00008-6 · Cited by 3
Ordyan, N. E., Malysheva, O. V., Kholova, G. I., Акулова, В. К., & Пивина, С. Г. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01232-4 · Cited by 3
“Decreases in Igf2 expression during intrauterine development lead to delayed fetal growth and even fetal death [Bergman et al., 2013].”
BackgroundInsights to maternal regulation of the paternal genome in mammalian livestock embryos: A mini-review
Daigneault, B. W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.909804 · Cited by 4
“In humans, growth disorders attributed to IGF2 include Beckwith–Wiedemann (overgrowth) and Silver–Russel (growth restricting) syndromes (Bergman et al., 2013).”
BackgroundChanges on chromosome 11p15.5 as specific marker for embryonal rhabdomyosarcoma?
Vícha, A., Jenčová, P., Kodetova, D. N., Štolová, L., Voříšková, D., Vyletalova, K., Brož, P., Drahokoupilová, E., Guha, A., Kopecká, M., et al. (2023) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23194 · Cited by 3
“33 The mRNA IGF2 overexpression can be directly regulated by methylation of IGF2 gene.”
BackgroundMichaux, H., Halouani, A., Trussart, C., Renard, C., Jaïdane, H., Martens, H., Hober, D., & Geenen, V. (2021) · Microorganisms · doi:10.3390/microorganisms9020402 · Cited by 3
“The murine Igf2 gene comprises three main promoters (Igf2 P1, Igf2 P2, and Igf2 P3), resulting in three transcript isoforms differing only in their first exon in the 5′ untranslated region: Igf2 Variant 3 (Igf2 P3), Igf2 Variant 1 (Igf2 P2), and Igf2 Variant 2 (Igf2 P1) [19].”
BackgroundShimizu, M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801028-0.00150-1 · Cited by 3
Insulin-like growth factor family and its impact on pulmonary arterial hypertension: a review
Li, N., Mo, D.-G., & Dai, H. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1679278 · Cited by 4
“…its effects through binding to the IGF-2 receptor (IGF-2R), influencing cellular growth, differentiation, and metabolism (DeChiara et al., 1990; Bergman et al., 2013),and it plays a crucial role in cardiovascular health by promoting cardiac cell growth and repair, influencing vascular smooth…”
Kaneko, N., Ishikawa, T., Fukui, Y., Nomura, K., Ichihara, A., Nagatani, K., Tanaka, H., & Ishibashi, Y. (2025) · Aquaculture · doi:10.1016/j.aquaculture.2025.743349 · Cited by 2
Strzałka‐Mrozik, B., Kimsa-Furdzik, M., Kabiesz, A. M., Michalska‐Małecka, K., Nita, M., & Mazurek, U. M. (2017) · Clinical Interventions in Aging · doi:10.2147/cia.s135030 · Cited by 2
“Although both IGF1 and IGF2 can easily be detected in plasma, 32 Haurigot et al 10 showed that an increased intraocular but not systemic level of IGF1 can cause a disruption of blood–retinal barrier (BRB), which leads to various ocular diseases.”
DNA methylation status of P2 promoter of IGF2 gene in growth restricted neonates
Sibin, M. K., Hothi, O., Misra, P., Manoj, P., Chakravarty, R., Shaw, S. C., & Kanitkar, M. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101153 · Cited by 2
Introduction to Cancer Biomarkers
Iftikhar, M., Younis, A., Lee, Y. S., & Shehzad, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-5759-7_1 · Cited by 3
Nor, N. H. M., Berahim, Z., Ahmad, A., & Kannan, T. P. (2022) · Sains Malaysiana · doi:10.17576/jsm-2022-5109-21 · Cited by 2
Mohammed, N. I., Alzubaidi, Z. F., & Khudhair, M. K. (2022) · Wiadomości Lekarskie · doi:10.36740/wlek202211215 · Cited by 2
Impact of Maternal Folic Acid Supplementation on Descendants' Kidney in Adulthood
Fernandes, T. F. D. C., Conde, P. D. S., Brasil, F. B., & de Oliveira, M. R. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1769001 · Cited by 4
“Igf2 promotes fetal growth, 52 meanwhile Er-α is an estrogen nuclear receptor which allows the action of such hormone on reproductive development in embryo and fetus.”
BackgroundLiu, X., Liu, X., Zhang, Y., Liu, Y., Lv, L.-W., Wang, M., Ren, Q., Liu, Y., Wu, M.-Z., Shi, Y., et al. (2025) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2025.06.046 · Cited by 3
Aria, F., Arp, C. J., Prikas, E., Goodwin‐Groen, S., Pandey, K. R., Munari, L., Patel, S., Trauner, D. H., & Alberini, C. M. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03610-1 · Cited by 2
“Studies in healthy mice and rats have shown that the administration of IGF2 (or IGFII), a small protein of 67 amino acids belonging to the insulin-IGF system [4, 5], promotes stronger and more prolonged memories [6 – 12].”
Mullen, E. A., Kreidberg, J. A., & Weldon, C. B. (2015) · Springer eBooks · doi:10.1007/978-3-642-27843-3_80-1 · Cited by 2
Beyond Sex Differences: Genes, Brains and Matrilineal Evolution
Keverne, E. B. (2017) · Cited by 2
Umaña‐Pérez, A., Novoa-Herrán, S. S., Castro, J. J., Correa-Sánchez, A. F., Guevara, V., López-González, D. A., & Sánchez-Gómez, M. (2020) · Medical Research Archives · doi:10.18103/mra.v8i10.2247 · Cited by 2
Lloyd, D., Skinner, H. G., Maguire, R. L., Murphy, S. K., Motsinger‐Reif, A. A., Hoyo, C., & House, J. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810450 · Cited by 4
“In contrast, the nearby paternally-expressed IGF2 gene that encodes insulin-like growth factor 2 is involved in fetoplacental development and growth and has been implicated in both cancer and cardiovascular disease [26].”
BackgroundKrapf, S. A., Lund, J., Saqib, A. U. R., Bakke, H. G., Rustan, A. C., Thoresen, G. H., & Kase, E. T. (2022) · Metabolites · doi:10.3390/metabo12111095 · Cited by 2
“These are tumor growth promotors and, therefore, often increased in different tumors [40].”
BackgroundContexto, ser humano y epigenética
Ceberio, M. R., & Berardino, B. G. (2022) · Interdisciplinaria Revista de Psicología y Ciencias Afines · doi:10.16888/interd.2023.40.1.5 · Cited by 3
Gandhi, G., Kodiappan, R., Abdullah, S., Teoh, H. K., Tai, L., Cheong, S. K., & Yeo, W. W. Y. (2024) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlae065 · Cited by 2
“58 Apart from this, IGF2 is needed to activate this pathway by activating the IGF1 receptor 59,60 and thought to play a pivotal function in neuronal survival.”
BackgroundNon–Islet-Cell Tumor Hypoglycemia Secondary to Malignant Phyllodes Tumor of the Breast
Lee, S. M., Quek, T. P. L., Seow, C. J., & Yeo, P. S. (2024) · AACE Clinical Case Reports · doi:10.1016/j.aace.2024.07.002 · Cited by 3
Lacey, T. E., Fame, R. M., & Lehtinen, A. M. K. (2023) · Wiley eBooks · doi:10.1002/9781119860914.ch32 · Cited by 1
Associations Between IGF-II Gene Polymorphism and Milk Yield Characteristics In Brown Swiss Cattle
Yuca, E., & Kopuzlu, S. (2023) · Turkish Journal of Agriculture - Food Science and Technology · doi:10.24925/turjaf.v11i6.1060-1066.5199 · Cited by 1
“Adult IGF-II expression occurs in epithelial cells covering the liver and brain surface (Bergman et al., 2013).”
Liu, X., Chen, L., Chen, Y., Huang, Y., Xiao, X., & Zhong, X. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70361 · Cited by 3
“14 IGF2, initially identified as a core regulatory factor for foetal growth and development, promotes cell proliferation, differentiation, and the development of tissues and organs.”
Ge, Y., Huan, N., Sun, J., Chao, T., Zhao, X., & Wang, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1724232 · Cited by 1
“Loss of imprinting of the IGF2 gene has been found in a variety of tumors, including breast, lung and colon cancers (Bergman et al., 2013).”
Maternal Energetics and the Developmental Origins of Prostate Cancer in Offspring
Benesh, E. C., & Moley, K. H. (2015) · Energy balance and cancer · doi:10.1007/978-3-319-16733-6_11 · Cited by 1
Efremov, Y. R., Proskurina, A. S., Potter, E. A., Долгова, Е. В., Efremova, O. V., Kolchanov, N. A., & Bogachev, S. S. (2019) · Mathematical Biology and Bioinformatics · doi:10.17537/2019.14.160 · Cited by 1
Metadata
- Authors
- Bergman, D., Halje, M., Nordin, M., & Engström, W.
- Affiliations
- Swedish University of Agricultural Sciences (SE)
- ORCID
- Bergman, Daniel
- Venue
- Gerontology
- Publisher
- S. Karger AG
- Published
- 2012-12-20
- Volume
- 59
- Issue
- 3
- Pages
- 240-249
- ISSN
- 0304-324X (ISSN-L)
- 1423-0003
- OpenAlex
- W1976143235
- Cited by
- 260
- References
- 35
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 27 · 2023: 21 · 2022: 27 · 2021: 35 · 2020: 37 · 2019: 13 · 2018: 15 · 2017: 15 · 2016: 17 · 2015: 17 · 2014: 15 · 2013: 3
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Gerontology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Syndromes and Imprinting
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Keywords
- insulin-like growth factor II, genomic imprinting, loss of imprinting, overgrowth syndromes, cancer, breast cancer, colon cancer, lung cancer, cardiovascular disease, atherosclerosis, IGF-II receptor, apoptosis, tumor growth, geriatrics
- MeSH terms
- Animals, Cardiovascular Diseases, Disease, Female, Humans, Insulin-Like Growth Factor II, Male, Neoplasms, Protein Processing, Post-Translational, Receptor, Insulin, Signal Transduction, Receptor, IGF Type 1, Receptor, IGF Type 2, Genomic Imprinting, Insulin-Like Growth Factor Binding Proteins, Growth and Development, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.